Comprehensive Medication Management Note (Initial Assessment)

A structured initial assessment template for clinical pharmacists performing comprehensive medication management. Follows the PPCP framework with prioritized medication therapy problem identification, detailed medication…

Document Type

clinical note / Initial Evaluation Note

Specialties

Pharmacy
Created by Augustun

Template Preview

Note Type: Comprehensive Medication Management Note (Initial Assessment)

Encounter Date/Time: [Encounter date and time]

Setting/Modality: [in-person / video / phone]; [Clinic or site name]

Participants: [Patient name or initials]; [Caregiver(s) if present]; [Interpreter used: yes/no; language if applicable]

Author: [Pharmacist name, credentials]

Referral Source: [Referring clinician or service]

Reason for Referral: [Referral question or concern]

Primary Care Provider: [Name, specialty]

Preferred Pharmacy: [Pharmacy name, location, contact]

Reason for Visit and Patient Goals

(Use 2–6 concise bullets. Include direct quotes for impactful patient-stated goals. Patient goals are required for initial CMM encounters.)

  • [Chief concern or referral question]
  • [Patient-stated goal(s) in their own words]
  • [Medication-related concerns: side effects, cost/access, regimen confusion, adherence challenges]
  • [Specific outcomes patient prioritizes: symptom relief, lab/vital targets, quality-of-life measures]
  • [Other expectations or preferences relevant to therapy decisions]

Medication Experience and Relevant History

(Format as 1–2 short paragraphs. Attribute sources for key facts: patient-reported, caregiver, EHR, pharmacy fill history, external records.)

[Narrative summary of medication experience including perceived benefits/harms, prior successes/failures, preferences/beliefs about medicines, adherence patterns and timing, missed doses, administration technique; use of adherence aids; access/cost/coverage barriers including copays, formulary, prior authorization needs; relevant social factors impacting medication outcomes.]

[Brief summary of active medical problems relevant to medication decisions; recent hospitalizations/ED visits; pregnancy or lactation status if applicable.]

Allergies, Intolerances, and Adverse Reactions

(List each agent on a separate line. Distinguish allergy vs intolerance vs side effect. If reaction unknown, document explicitly with plan to clarify.)

  • [Agent] — [Allergy / Intolerance / Side effect]; Reaction: [reaction]; Severity: [mild / moderate / severe]; Onset: [approximate date or period]; Re-challenge: [yes / no / unknown]; Source: [patient / EHR / caregiver / pharmacy]
  • [Additional agents as applicable]

Current Medication List (Reconciled)

Medication Reconciliation Statement: Reconciliation performed using: [patient interview / medication bottles / EHR medication list / pharmacy fill records / claims data / discharge summary / caregiver report]. Discrepancies identified: [list each with source and resolution status, or "none identified"]. Pending verifications: [items requiring confirmation and plan to obtain, or "none"].

Prescription Medications

Medication (generic; brand if relevant) Strength/Dose Route Frequency/Schedule Indication How Patient Actually Takes It Prescriber Monitoring Notes
[Medication name] [Strength/Dose] [Route] [Frequency/Schedule] [Indication] [Actual use; adherence notes; PRN usage; timing] [Prescriber] [Monitoring needs; safety concerns; access issues]

OTC / Nonprescription

(If none, document "None reported.")

Medication Strength/Dose Route Frequency/Schedule Indication How Patient Actually Takes It Prescriber Monitoring Notes
[Medication name] [Strength/Dose] [Route] [Frequency/Schedule] [Indication] [Actual use/adherence] [Prescriber or N/A] [Monitoring/access notes]

Supplements / Herbals

(If none, document "None reported.")

Product Strength/Dose Route Frequency/Schedule Indication/Purpose How Patient Actually Takes It Prescriber Monitoring Notes
[Product name] [Strength/Dose] [Route] [Frequency/Schedule] [Indication/Purpose] [Actual use/adherence] [Prescriber or N/A] [Monitoring/access notes]

Pertinent Objective Data

(Include most recent values first with dates and sources. If key data unavailable, document what was ordered/requested.)

  • Vital signs: [BP, HR, weight/BMI] — Source: [clinic / home device]; Date: [date]. [Home readings summary if provided]
  • Renal function: [SCr, eGFR] — Date: [date]
  • Electrolytes: [Na, K, Mg, Ca] — Date: [date]
  • Hepatic function: [AST, ALT, ALP, Tbili, Albumin] — Date: [date]
  • Glycemic control: [A1c]; [SMBG/CGM summary if available] — Date: [date]
  • Lipids: [TC, LDL, HDL, TG] — Date: [date]
  • Anticoagulation/drug levels: [INR, anti-Xa, drug level if applicable] — Date: [date]
  • Other pertinent data: [Relevant diagnostics, immunization status]
  • Pending/unavailable: [Data element] ordered/requested from [source]; expected [timeframe]

Assessment: Medication Therapy Problems

(Provide a prioritized list. For each MTP, include actionable title, linked conditions/medications, brief supporting evidence, MTP domain, and alignment with patient goals. If no MTPs identified, document: "No medication therapy problems identified today. Current regimen assessed as appropriate, effective, safe, and patient able to take as intended based on available information.")

#[1] ([High / Moderate / Low] Priority – [Indication / Effectiveness / Safety / Adherence]): [Actionable MTP title]

  • Linked conditions/medications: [Condition(s)]; [Medication(s)]
  • Evidence: [Symptoms, objective data, patient report, fill history]
  • MTP Domain: [Indication / Effectiveness / Safety / Adherence]
  • Goal alignment: [How resolving this advances patient's stated goals]

#[2] ([High / Moderate / Low] Priority – [Indication / Effectiveness / Safety / Adherence]): [Actionable MTP title]

(Add additional problems as needed.)

  • Linked conditions/medications: [Condition(s)]; [Medication(s)]
  • Evidence: [Brief supporting data]
  • MTP Domain: [Indication / Effectiveness / Safety / Adherence]
  • Goal alignment: [How this advances patient goals]

Plan

(Organize by problem corresponding to the Assessment. Use explicit language: "Recommendation to prescriber:" for suggestions requiring approval; "Ordered/prescribed under CPA:" for executed changes; "Patient instructed:" for self-management guidance.)

Problem #[1]: [Actionable MTP title]

  • Therapeutic Goal: [Specific, measurable target with timeframe]
  • Medication Plan:
    • Recommendation to prescriber: [start/stop/change; drug, dose, route, schedule; rationale]
    • Ordered/prescribed under CPA: [action executed today with details]
    • Patient instructed: [self-management guidance; titration instructions; missed-dose instructions]
  • Non-pharmacologic Plan: [Lifestyle modifications, device technique education, adherence tools initiated]
  • Monitoring: [What to monitor]; [when/timeframe]; [responsible party]; [action thresholds]
  • Implementation Status: [Completed today vs pending tasks]
  • Communication: [Who notified, method, summary of information transmitted]

Problem #[2]: [Actionable MTP title]

  • Therapeutic Goal: [Target]
  • Medication Plan: [Details]
  • Non-pharmacologic Plan: [Details]
  • Monitoring: [Details]
  • Implementation Status: [Details]
  • Communication: [Details]

Patient Education and Shared Decision-Making

  • [Medication counseling provided: indications, key side effects, administration technique, missed-dose instructions]
  • [Risk-benefit discussion for high-risk changes; patient preferences considered]
  • [Teach-back used: yes/no]; Patient demonstrated understanding of: [topics]
  • [Materials provided: written plan, medication list, device instructions, adherence supports]

Care Coordination

  • [Date] — [Recipient/role] via [EHR message / phone / fax]: [Summary of communication]
  • Referrals placed: [Service, reason, status]
  • Prior authorization/coverage: [Medication, payer, status/next steps]
  • Transitions-of-care coordination: [Discharge reconciliation, outreach, handoffs if applicable]

Follow-up Plan

  • Next visit: [Timeframe] via [in-person / video / phone]
  • Reassess: [Specific MTPs, labs, vitals, symptoms, adherence to evaluate]
  • Interim monitoring: [Phone call, refill monitoring, device data review] by [responsible party] around [date]
  • Red-flag symptoms/escalation: [What to watch for; whom/how to contact; emergency instructions]

(If no follow-up scheduled, document reason and monitoring handoff plan.)

Want to use this template?

Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.